Literature DB >> 23381309

Point: should systemic lytic therapy be used for submassive pulmonary embolism? Yes.

David Jiménez1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381309     DOI: 10.1378/chest.12-2447

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

Review 1.  Potential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspectives.

Authors:  Mohamed Teleb; Mateo Porres-Aguilar; Javier E Anaya-Ayala; Carlos Rodriguez-Castro; Mateo Porres-Muñoz; Debabrata Mukherjee
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-02-09

2.  Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis.

Authors:  Qixia Xu; Ke Huang; Zhenguo Zhai; Yuanhua Yang; Jun Wang; Chen Wang
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

3.  Half-dose alteplase for sub-massive pulmonary embolism directed by emergency department point-of-care ultrasound.

Authors:  Richard Amini; Ashish R Panchal; David Bahner; Srikar Adhikari
Journal:  West J Emerg Med       Date:  2015-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.